Heart transplant patient who had to be hooked up to machines to walk his daughter down the aisle will compete in Olympic-style sporting events at this year's Transplant Games of America.
The operating rooms where Dr. Michael E. DeBakey and others performed the firsts in the heart surgery will close as the Houston Methodist DeBakey Heart & Vascular Center moves to a new high-tech building.
Richard Pollitt was at the end of his rope after years of suffering regular seizures, with some lasting five minutes and preventing him from working and enjoying his favorite pastimes. Desperate for relief after medications did not work, Pollitt had a small battery-powered device implanted in his skull to control seizures. Now he rarely has them.
Beginning July 1, James M. Musser, M.D., Ph.D., becomes the 2018-2019 president of the Federation of American Societies for Experimental Biology (FASEB).
A Houston Methodist program that provides specialty patient care to uninsured and underserved patients received another multi-million dollar gift from Occidental Petroleum Corporation.
The American Cancer Society's recent recommendations for changing the colorectal cancer screening age to 45 from age 50 had significant meaning for a Magnolia, Texas woman.
Researchers at Houston Methodist Research Institute and The University of Texas MD Anderson Cancer Center have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. Their preclinical research was reported in the Journal of the National Cancer Institute.
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.
Houston Methodist researchers developed a new lab-on-a-chip technology that could quickly screen possible drugs to repair damaged neuron and retinal connections, like what is seen in people with macular degeneration or who’ve had too much exposure to the glare of electronic screens.
Patients with cholangiocarcinoma, a form of liver cancer, were never candidates for liver transplant in the past. However, a new study looking at treating these patients with chemotherapy treatment first.
Houston Methodist Global Health Services is working with the Kingdom of Saudi Arabia and the Ministry of Health to decrease sepsis across the entire area.
A rare, inherited neurodegenerative disorder will soon be the focus of an international clinical research effort led by Houston Methodist and funded by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health.
Researchers at Houston Methodist used computer modeling to find an existing investigational drug compound for leukemia patients to treat triple negative breast cancer once it spreads to the brain.
One of the nation’s leading cardiologists is challenging the new hypertension guidelines, perhaps sparing up to 10 million people from unnecessarily aggressive blood pressure treatments. His team’s study results appear March 7 in the Journal of the American College of Cardiology.
A metal plate might be the cure for a common foot injury seen in athletes and people on their feet all day, according to new research conducted at Houston Methodist.
This year’s flu season has been one of the worst in recent memory causing thousands of people to be hospitalized. The virus can be particularly dangerous for young men who can experience nerve damage caused by the body’s response to the flu.
Houston Methodist Hospital performed its 1000th heart transplant. The hospital's first was performed by Dr. Michael DeBakey in 1968 as part of the world's first multi-organ transplant. The patient is a 23-year old man who suffers from Becker's Muscular Dystrophy, a rare form of the disease that damages the heart.
More than 1 million people undergo total joint replacements each year, and nearly 10,000 will develop infections. To reduce this infection risk, a Houston Methodist orthopedic surgeon created small antibiotic beads that are implanted with the new joint to slowly release medicine for several weeks.
Researchers at Houston Methodist believe that a significant number of people diagnosed with schizophrenia or bipolar disorder may actually have a treatable immune system condition. A new research study could have a significant impact on the millions diagnosed with schizophrenia or bipolar disorder, including many homeless.
The holiday season is filled with travel as many families drive or fly to spend time with loved ones, but traveling with a disability can create unique challenges for some families.
People who have lived though natural disasters such as Hurricane Harvey are under a great amount of stress putting their lives back together. A cardiologist tells us that this type of stress, in a roundabout way, can do damage to the heart.
A new study shows that a 70-year-old malaria drug can block immune cells in the liver so nanoparticles can arrive at their intended tumor site, overcoming a significant hurdle of targeted drug delivery, according to a team of researchers led by Houston Methodist.
A team of Houston Methodist researchers and clinicians received two grants totaling over $15.7 million from the Department of Defense (DoD) to accelerate a possible treatment for metastatic breast cancer.
Houston Methodist cancer researchers are now closer to creating a blood test that can identify breast cancer patients who are at increased risk for developing brain metastasis, and also monitor disease progression and response to therapy in real time.
Athletes at all levels are pressured to be physically superior, which can cause many to overlook their mental health needs.
Heart disease is the number one killer of women. However, most women are not treated for the disease until they in their 50s and 60s. This release talks about how women with risk factors need to talk to their doctors in their 40s and get ahead of the game. Also mentions recent study on subject.
Houston Methodist is launching the Center for Immunotherapy Research under the leadership of Shu-Hsia Chen, Ph.D., a cancer immunotherapy researcher recruited from Icahn School of Medicine at Mount Sinai.
Researchers from Houston Methodist and Italian super sports car maker Automobili Lamborghini are working together on new carbon fiber materials for implantable devices used in therapeutic drug delivery and orthopedics.
Research led by a Houston Methodist gastroenterologist shows that patients who have inflammatory bowel disease (IBD) for more than two decades have a higher risk of developing nonalcoholic fatty liver disease (NAFLD).
A Houston Methodist-led research team showed that the systemic administration of nanoparticles triggers an inflammatory response because of blood components accumulating on their surface.
Just because there is no tackling, jumping or running does not mean golfers are immune to injury.
Medtronic plc (NYSE: MDT) today unveiled first-ever clinical data from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Trial, which was presented at the American College of Cardiology (ACC) 66th Annual Scientific Session and published simultaneously in The New England Journal of Medicine (NEJM) (1).
A new stent opens up iliac arteries, the three arteries that run from the end of the aorta down to the pelvis and legs. When these arteries are clogged it can cause a whole host of problems.
A pacemaker the size of a nickel can now be implanted in patients.
Beginning in the mid-1980s, an epidemic of severe invasive infections caused by Streptococcus pyogenes (S. pyogenes), also known as group A streptococcus (GAS), occurred in the United States, Europe, and elsewhere. The public became more aware of these sometimes fatal infections, commonly known as the “flesh-eating disease.” A new study in The American Journal of Pathology reports that the bacteria’s full virulence is dependent on the presence of two specific cytotoxins.
Researchers are looking at a drug once used to improve blood flow in damaged hearts in thousands of patients as a possible treatment option for triple negative breast cancer (TNBC).
Women often neglect their own heart health during the holidays and can suffer serious health problems.
The Houston Methodist Research Institute’s department of nanomedicine is the recipient of this year’s AIDS Foundation Houston Shelby Hodge Vision Award. Alessandro Grattoni, Ph.D., nanomedicine department chair at the Houston Methodist Research Institute, accepted the award during the World AIDS Day luncheon.
Dealing with Alzheimer’s disease can be difficult any time of year, but the holidays present unique challenges for patients and their families.
The holiday season sometimes brings with it excessive alcohol consumption. Women need to be aware that even a lit bit of holiday cheer can cause some serious health problems.
Study Highlights • Designed a smart drug that only targets and kills GBM brain cancer cells. • Validated a compound that sensitizes GBM tumors to chemotherapy and results in a significant extension of life in an animal model.
Calorie-laden meals, decadent treats, and festive drinks inundate people from Thanksgiving to New Year’s Day, inviting the fiery sensation of heartburn and bitter taste of reflux as unwelcome guests to the holiday festivities.
Millions of people will be traveling next week for Thanksgiving. Deep vein thrombosis can fatal for travelers if they sit for too long on a plane or in a car.
Research published by a Houston Methodist team led by John Cooke, M.D., Ph.D., received high accolades at this year’s American Heart Association Scientific Sessions.
The holiday season is officially in full gear and with it comes the tempting Thanksgiving-to-New-Year’s food fest. During the holiday season, good eating habits spiral out of control and exercise plans are thrown out the window resulting in undesired weight gain.
The Houston Texans and GE are collaborating with the Houston Methodist Concussion Center to fund a two-year pilot project to bring specialized concussion care via telemedicine to athletes in rural areas.
Houston Methodist researchers have discovered a set of immune proteins that facilitate long-lasting immunity against malaria. In a study recently published in Immunity (online Oct. 25), researchers reported that elevated production of specific proteins regulating the immune system within 24 hours of infection was required for a resilient and sustained anti-malaria immunity in mice.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right